Welcome to the Australian Centre for NanoMedicine (ACN) PDF Print E-mail

The Australian Centre for NanoMedicine combines Medicine, Science and Engineering to deliver therapeutic solutions to research problems in medicine. Through a commitment to research, education, knowledge transfer and commercialisation, ACN is dedicated to the prevention, diagnostics and curing of diseases.

Global effort has been made to conquer incurable diseases by developing new advanced medical technologies that utilise a multidisciplinary research approach of converging nano- and medical research.

The Australian Centre for NanoMedicine (ACN) based at UNSW Australia (The University of New South Wales), is a unique translational research centre that brings together teams combining the skills of medics, scientists and engineers to undertake basic, clinical and technological research. ACNs focus is directed at increasing capabilities in specific disease focused programs within four areas:

  • Theranostics
  • Drug and Gene Delivery
  • Nanomaterials and Bioimaging
  • Regenerative Medicine

With alliances that span Australia and international medical and research institutions, ACN has enormous potential and to influence future clinical care, especially for those patients with cancer, diabetics, cardiovascular diseases, multiple sclerosis, Alzheimer’s and Parkinson’s disease and inflammatory and/or infectious diseases and other diseases.

facebook Like ACN on Facebook


Conference Update

Featured links:
International NanoMedicine Conference 2015
Taking place at Crowne Plaza Hotel Coogee Beach Sydney July 6-8 2015. More details coming soon.


Prof Maria Kavallaris joins the National Health and Medical Research Council's (NHMRC) prestigious list of High Achievers in Australian Health and Medical Research.

Maria's work investigates how nanotechnology may be used to develop cancer therapies with fewer harmful side effects than most existing treatments


ACNs Dr Orazio Vittorio was interviewed by the BBC on his personal journey with cancer. This journey saw Orazio move to Australia in February 2013 to join ACN on its work in finding a solution for childhood cancer


Prof Justin Gooding received a NHMRC Development Grant to develop a portable device that can measure glycosylated haemoglobin (HbA1c) in the home.


Like ACN on Facebook

July 2013 ACN Newsletter

ACN News Page Click Here

ACN in the Media Click Here

ACN Publications Click Here

Team ACN Presentations Click Here